Novartis Ag (NVS) Inventory Average (2009 - 2026)

Novartis Ag has disclosed Inventory Average across 18 years of filings, most recently posting $6.3 billion for Q2 2026.

• In Q2 2026, Inventory Average rose 3.05% year-over-year to $6.3 billion; the TTM figure through Jun 2026 stood at $6.3 billion (up 3.05% YoY), while the FY2025 annual figure was $6.0 billion, up 3.06% from the prior year.
• Inventory Average came in at $6.3 billion for Q2 2026 at Novartis Ag, roughly flat from $6.3 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $8.1 billion in Q2 2023 to a low of $5.7 billion in Q2 2024.
• Average Inventory Average over 5 years is $6.5 billion, with a median of $6.3 billion recorded in 2025.
• Year-over-year, Inventory Average increased 16.12% in 2023 and retreated 28.7% in 2024.
• Over 5 years, Inventory Average stood at $7.0 billion in 2022, then declined by 17.42% to $5.8 billion in 2023, then climbed by 1.21% to $5.8 billion in 2024, then gained by 8.81% to $6.3 billion in 2025, then fell by 1.45% to $6.3 billion in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $6.3 billion in Q2 2026, $6.3 billion in Q1 2026, and $6.3 billion in Q4 2025.